Valens (NYSE:VLN) specializes in cannabis products and services, focusing on developing proprietary extraction techniques, formulation and distribution. The company’s operations span across various segments of the cannabis industry, including extraction, analytical testing, formulation and product development. Valens aims to capitalize on the growing demand for innovative and high-quality cannabis products both in the recreational and medical markets. Through strategic partnerships, research, and development, Valens works to enhance its product offerings and expand its market reach, consistently striving to meet and exceed industry standards for quality and safety. The company's objective is to become a key player in the cannabis sector by delivering superior value to its customers and shareholders alike.